Susanne Bryde

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort

C. Catsman-Berrevoets, R. Hintzen, D. Hamann, 2015, Multiple sclerosis.

Nanocapsules of platinum anticancer drugs: development towards therapeutic use.

Susanne Bryde, A. D. de Kroon, 2009, Future medicinal chemistry.

Characterisation of TNF receptor-2 mediated signal initiation and transduction

Susanne Bryde, Susanne Bryde, 2004 .

Proteins involved in lipid translocation in eukaryotic cells.

I. López-Montero, P. Devaux, Susanne Bryde, 2006, Chemistry and physics of lipids.

CDC50 Proteins Are Critical Components of the Human Class-1 P4-ATPase Transport Machinery*

P. Devaux, G. Lenoir, J. Holthuis, 2010, The Journal of Biological Chemistry.

Control of Receptor-induced Signaling Complex Formation by the Kinetics of Ligand/Receptor Interaction*

Peter Scheurich, P. Scheurich, G. Zimmermann, 2002, The Journal of Biological Chemistry.

Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-specific cell responses.

Peter Scheurich, Herwig Brunner, Klaus Pfizenmaier, 2005, Bioconjugate chemistry.